[Role of CD4+CD25+Foxp3+ regulatory T cells in type 2 diabetic nephropathy]

Jing Xu1, Hong-li Su, Jun-hong Wang

  • 1Department of Endocrinology, Second Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an 710004, China. xujingj dey85@163.com

Abstract

Insights

Regulatory T cells (Treg) are reduced in type 2 diabetic nephropathy, particularly in advanced stages with macroalbuminuria. Lower Treg cell expression correlates with disease severity and urinary albumin excretion, suggesting a role in disease progression.

Area of Science:

  • Immunology
  • Nephrology
  • Endocrinology

Background:

  • Type 2 diabetic nephropathy (T2DN) is a major complication of type 2 diabetes.
  • Regulatory T cells (Treg) play a crucial role in immune homeostasis and preventing autoimmunity.
  • The specific role of Treg cells in T2DN pathogenesis remains incompletely understood.

Purpose of the Study:

  • To investigate the involvement of CD4+CD25+Foxp3+ Treg cells in T2DN.
  • To explore potential therapeutic targets for T2DN prevention and treatment.

Main Methods:

  • Flow cytometry was employed to quantify CD4+CD25+Foxp3+ Treg cell expression rates.
  • Analysis included 60 patients with T2DN and 15 healthy controls.
  • Patients were stratified based on urinary albumin excretion (microalbuminuria vs. macroalbuminuria).

Main Results:

  • No significant difference in Treg cell expression was observed between all T2DN patients and controls.
  • Treg cell expression was significantly lower in T2DN patients with microalbuminuria and macroalbuminuria compared to controls.
  • Patients with macroalbuminuria exhibited significantly lower Treg cell expression than those with microalbuminuria.
  • A significant inverse correlation was found between Treg cell expression and disease duration.
  • Urinary albumin excretion rate (UAER) showed a significant inverse correlation with Treg cell expression.

Conclusions:

  • CD4+CD25+Foxp3+ Treg cells are implicated in the development and progression of type 2 diabetic nephropathy.
  • Reduced Treg cell function may contribute to the pathogenesis of T2DN.
  • Modulating Treg cell activity could be a potential therapeutic strategy for T2DN.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...